Resistome analysis of Mycobacterium tuberculosis: Identification of aminoglycoside 2'-Nacetyltransferase (AAC) as co-target for drug desigining

Article (PDF Available)inBioinformation 9(4):174-81 · February 2013with60 Reads
DOI: 10.6026/97320630009174 · Source: PubMed
Unlabelled: : The emergence of multidrug resistant tuberculosis (MDRTB) highlights the urgent need to understand the mechanisms of resistance to the drugs and to develop a new arena of therapeutics to treat the disease. Ethambutol, isonazid, pyrazinamide, rifampicin are first line of drugs against TB, whereas aminoglycoside, polypeptides, fluoroquinolone, ethionamide are important second line of bactericidal drugs used to treat MDRTB, and resistance to one or both of these drugs are defining characteristic of extensively drug resistant TB. We retrieved 1,221 resistant genes from Antibiotic Resistance Gene Database (ARDB), which are responsible for resistance against first and second line antibiotics used in treatment of Mycobacterium tuberculosis infection. From network analysis of these resistance genes, 53 genes were found to be common. Phylogenetic analysis shows that more than 60% of these genes code for acetyltransferase. Acetyltransferases detoxify antibiotics by acetylation, this mechanism plays central role in antibiotic resistance. Seven acetyltransferase (AT-1 to AT-7) were selected from phylogenetic analysis. Structural alignment shows that these acetyltransferases share common ancestral core, which can be used as a template for structure based drug designing. From STRING analysis it is found that acetyltransferase interact with 10 different proteins and it shows that, all these interaction were specific to M. tuberculosis. These results have important implications in designing new therapeutic strategies with acetyltransferase as lead co-target to combat against MDR as well as Extreme drug resistant (XDR) tuberculosis. Abbreviations: AA - amino acid, AT - Acetyltransferase, AAC - Aminoglycoside 2'-N-acetyltransferase, XDR - Extreme drug-resistant, MDR - Multidrug-resistant, Mtb - Mycobacterium tuberculosis, TB - Tuberculosis.
    • "Hence, depending on its size and on its type (open or closed), we can determine the species' lifestyle (allopatry or sympatry), and also have an idea of the number of genomes we need to have the best view of real genomic content (Fig. 3). Pangenome study also allowed us to find the resistome [47], the non-virulence genes [62] and the mobilome [48] (to determine selfish genes) of a group of strains(Fig. 4). "
    [Show abstract] [Hide abstract] ABSTRACT: The bacterial pangenome was introduced in 2005 and, in recent years, has been the subject of many studies. Thanks to progress in next-generation sequencing methods, the pangenome can be divided into two parts, the core (common to the studied strains) and the accessory genome, offering a large panel of uses. In this review, we have presented the analysis methods, the pangenome composition and its application as a study of lifestyle. We have also shown that the pangenome may be used as a new tool for redefining the pathogenic species. We applied this to the Escherichia coli and Shigella species, which have been a subject of controversy regarding their taxonomic and pathogenic position.
    Full-text · Article · Jun 2015
  • [Show abstract] [Hide abstract] ABSTRACT: PAX gene family members, tissue specific transcription factors mainly involved in the formation of tissues and organs during embryonic development and has important role in transcriptional regulation. The presence of consensus paired domain play significant role in DNA-binding transcription regulation with PAX domain. Regulatory behavior of PAX family members were determined using cis-acting elements study and repeat identification. The study helped in investigating the potential conserved motifs in the paired domain. Further, investigation of cis-acting elements was done to elucidate the function for each PAX members and then repeat analyses and their correlation with functional elements were done. The study illustrates that the cis-acting elements are involved in tissue specific developmental expression and transcriptional regulation of PAX family members. Further, based on physiochemical property study of these PAX gene family members it was found that they are mainly Ser, Pro, Gly and Ala rich amino acids. It was found that repeats containing functional DNA motifs interact with signature motifs of paired domain. The main six signature motifs NQLGG, NGRPLP, RPC, SR, GCVSKIL and PGAIGGSKP are involved in interaction. Altogether, this study provides new insights into the regulatory behavior of upstream region of each PAX members and its effect in transcriptional regulation and developmental expression of these PAX members with involvement in disease management.
    Full-text · Article · Mar 2013
  • [Show abstract] [Hide abstract] ABSTRACT: Antibacterial drug discovery is moving from largely unproductive high-throughput screening of isolated targets in the past decade to revisiting old, clinically validated targets and drugs, and to classical black-box whole-cell screens. At the same time, due to the application of existing methods and the emergence of new high-throughput biology methods, we observe the generation of unprecedented qualities and quantities of genomic and other omics data on bacteria and their physiology. Tuberculosis (TB) drug discovery and biology follow the same pattern. There is a clear need to reconnect antibacterial drug discovery with modern, genome-based biology to enable the identification of new targets with high confidence for the rational discovery of new drugs. To exploit the increasing amount of bacterial biology information, a variety of in silico methods have been developed and applied to large-scale biological models to identify candidate antibacterial targets. Here, we review key concepts in network analysis for target discovery in tuberculosis and provide a summary of potential TB drug targets identified by the individual methods. We also discuss current developments and future prospects for the application of systems biology in the field of TB target discovery.
    Full-text · Article · Jul 2013
Show more

Supplementary resources